Malignant melanoma of skin, unspecified Clinical Trials

12 clinical trials for Malignant melanoma of skin, unspecified across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

Assessing if stopping and starting standard of care medication for later stage melanoma can reduce the body's resistance to the treatment — RECRUITING · PHASE2
microRNA as prognostic and diagnostic markers in malignant melanoma. — RECRUITING
Diagnostic delay of malignant melanoma due to the corona-pandemic — RECRUITING
Training and validation of an automated diagnostic deep learning algorithm in dermoscopy — RECRUITING
Evaluation of immunological effects of the RANKL-inhibitor Denosumab when administered concurrently with PD1-blocking antibodies (Nivolumab, Pembrolizumab) in patients with metastatic malignant melanoma with bone involvement — OTHER
Early evaluation of therapy response (targeted therapy and immunotherapy) in patients with metastasized malignant melanoma by multiparametric PET/MR imaging. — OTHER
patients preferences for adjuvant therapy of malignant melanoma — NOT_YET_RECRUITING
Sentinel lymph node status determination using light sheet microscopy — OTHER
Non invasive visualization of biologic and topographic changes in (sub-)cutaneous melanoma metastases induced by antitumoral treatment — NOT_YET_RECRUITING
FeasiBIlity and efficacy of tRimodal supporting therapy During ImmunothErapy. Randomized, controlled, pilot trial — NOT_YET_RECRUITING
Survival rates of melanoma patients with sentinel diagnostics before and after the introduction of modern therapies (BRAF / MEK inhibition, anti-CTLA-4 antibodies, anti PD-1 antibodies). — OTHER
Active use of a sunscreen and quality of life in melanoma patients (feasibility study) — NOT_YET_RECRUITING

Refine this search